Graft Versus Host Disease
Corey S. Cutler, MD, MPH, FRCPC; Yi-Bin Chen, MD; and Haris Ali, MD, review currently available treatment options for acute and chronic GVHD and discuss the management of steroid-refractory disease.
EP. 1: Overview of Graft-Versus-Host Disease
Corey S. Cutler, MD, MPH, FRCPC; Yi-Bin Chen, MD; and Haris Ali, MD, provide insight on the nature of graft-vs-host disease (GVHD) and common risk factors for acute and chronic GVHD.
EP. 2: Diagnosis of Acute and Chronic GVHD
Hematologist-oncologists review the typical presentation and diagnosis of acute and chronic GVHD and define how severity is classified.
EP. 3: Role of GVHD Prophylaxis
A discussion on the role of prophylactic therapy for patients after transplant as well as available options for GVHD prophylaxis.
EP. 4: Initial Therapy in GVHD
Experts in hematology-oncology share insights on approaching initial treatment and the treatment goals for acute and chronic GVHD.
EP. 5: Treatment for Steroid-Refractory Acute GVHD
Defining steroid-refractory acute GVHD, treatment options for patients who don’t respond to steroid therapy, and a review of the REACH2 trial.
EP. 6: Treatment for Steroid-Refractory Chronic GVHD
A review of treatment options for patients with chronic GVHD who don’t respond to steroid therapy and preliminary findings from the phase 3 REACH3 trial.
